Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G C Parkes

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
International Journal of Clinical Practice|June 30, 2006
One man and his scopeG C Parkes, J D Sanderson
BMJ (Clinical Research Ed.)|November 6, 2007
Timing of surgery for inflammatory bowel diseaseJ D Sanderson, G C Parkes
Alimentary Pharmacology & Therapeutics|December 12, 2017
Editorial: avoiding corticosteroids in the treatment of inflammatory bowel disease-Author's replyC P Selinger, G C Parkes, T Raine
The Proceedings of the Nutrition Society|March 19, 2010
Treating irritable bowel syndrome with probiotics: the evidenceG C Parkes, J D Sanderson, K Whelan
Alimentary Pharmacology & Therapeutics|October 25, 2007
Review article: lactose intolerance in clinical practice--myths and realitiesM C E Lomer, G C Parkes, J D Sanderson
Neurogastroenterology and Motility|November 11, 2011
Distinct microbial populations exist in the mucosa-associated microbiota of sub-groups of irritable bowel syndromeG C Parkes, N B Rayment, B N Hudspith, et al.
Alimentary Pharmacology & Therapeutics|September 27, 2017
A multi-centre audit of excess steroid use in 1176 patients with inflammatory bowel diseaseC P Selinger, G C Parkes, A Bassi, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
International Journal of Clinical Practice|June 30, 2006
One man and his scopeG C Parkes, J D Sanderson
BMJ (Clinical Research Ed.)|November 6, 2007
Timing of surgery for inflammatory bowel diseaseJ D Sanderson, G C Parkes
Alimentary Pharmacology & Therapeutics|December 12, 2017
Editorial: avoiding corticosteroids in the treatment of inflammatory bowel disease-Author's replyC P Selinger, G C Parkes, T Raine
The Proceedings of the Nutrition Society|March 19, 2010
Treating irritable bowel syndrome with probiotics: the evidenceG C Parkes, J D Sanderson, K Whelan
Alimentary Pharmacology & Therapeutics|October 25, 2007
Review article: lactose intolerance in clinical practice--myths and realitiesM C E Lomer, G C Parkes, J D Sanderson
Neurogastroenterology and Motility|November 11, 2011
Distinct microbial populations exist in the mucosa-associated microbiota of sub-groups of irritable bowel syndromeG C Parkes, N B Rayment, B N Hudspith, et al.
Alimentary Pharmacology & Therapeutics|September 27, 2017
A multi-centre audit of excess steroid use in 1176 patients with inflammatory bowel diseaseC P Selinger, G C Parkes, A Bassi, et al.
Pageof 1